COMPARE · Data as of August 24, 2026

OMCL vs VEEV

Verdict: Side-by-side breakdown using the Bull Rankings model. OMCL scored 52.6, VEEV scored 78.0 — VEEV leads.
Compare another set
OMCL
Omnicell, Inc.
Health Information Services · Quality-Growth
52.6
$34.66 · $1.6B
fundamentals as of
Score gap
25.4
VEEV leads
VEEV
Veeva Systems Inc.
Health Information Services · Quality-Growth
78
$248.46 · $40.4B
fundamentals as of
  • CheapestOMCL42.3x
  • Fastest growthVEEV+16.2%
  • Strongest balance sheetVEEV0.01
  • Highest qualityVEEV77 / 100
  • Largest discount to fair valueOMCL-11%
THE BULL RANKINGS SCORECARD52.6/ 100 · BULL SCOREPEER MEDIANQUALITY47.5GROWTH59.5VALUE51.4
THE BULL RANKINGS SCORECARD78.0/ 100 · BULL SCOREPEER MEDIANQUALITY77.3GROWTH90.6VALUE67.9
OMCLVEEVQuality47.577.3Growth59.590.6Value51.467.9
cheap & fastrevenue growth →← cheaper (lower multiple)-2%26%37x49xOMCLVEEV

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFOMCL$143mVEEV$1.7b
RevOMCL+8.5%VEEV+16.2%
D/EOMCL0.15VEEV0.01
P/EOMCL42.3xVEEV43.9x
PEGOMCL15.40VEEV1.11
OMCL
stronger →← stronger
VEEV
48
Qualityreturns · margins · balance sheet
77
59
Growthrevenue & earnings expansion
91
51
Valuevaluation vs sector peers
68
VEEV is stronger on 3 of 3 pillars.
OMCL
VEEV
$143mC
FCF
$1.7bC+
+8.5%B
Rev
+16.2%B+
0.15B+
D/E
0.01A-
42.3xC
P/E
43.9xC
15.40D
PEG
1.11B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
OMCL
VEEV
11% below
Price vs fair valuelower is cheaper
30% above
~-4%/yr
Growth the price implies10-yr FCF · lower = less priced in
~14%/yr
+25%
1-yr DCF upside
-31%
+13%
5-yr DCF upside
-23%
-3%
10-yr DCF upside
-12%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
OMCLOmnicell, Inc.
Health Information Services · $34.66 · beta 0.97
Why now
Health Information Services · market cap $1.6b. Down 37% from 52-week high of $55.00 — deep drawdown territory. 7 sell-side analysts publish a mean 1-yr target of $57.86 (implying +67% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 42x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
VEEVVeeva Systems Inc.
Health Information Services · $248.46 · beta 0.92
Why now
Health Information Services · market cap $40.4b. 20% off the 52-week high of $310.50. Revenue growing +16%, comfortably above the S&P median. 28 sell-side analysts rate this a Buy with a mean 1-yr target of $253.57 (implying +2% upside).
Moat
Net margin 28% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 177% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 44x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. P/S 12.2x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where OMCL and VEEV diverge

On the headline score the gap is 25.4 points in favor of VEEV. The widest single difference is Growth, where VEEV leads by 31.1 points.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.